Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
The Berkshire Hathaway shareholders' meeting is coming! Warren Buffett stepped backstage for the first time in sixty years, what will the debut of the "new king" look like?
Kexilhasawei's operating profit in the first quarter increased by 18%, net profit increased by 120%, and cash reserves reached a record high.
EB SECURITIES: Maintains "buy" rating on PetroChina (00857) as 26Q1 performance hits new high.
The Berkshire Hathaway shareholders' meeting is coming! Warren Buffett stepped backstage for the first time in sixty years, what will the debut of the "new king" look like?
Kexilhasawei's operating profit in the first quarter increased by 18%, net profit increased by 120%, and cash reserves reached a record high.
EB SECURITIES: Maintains "buy" rating on PetroChina (00857) as 26Q1 performance hits new high.
